EUVIMEDEUVIMED entdecken
Crossref

A Novel Antibody Against the Non–Receptor-Binding Domain Region of Middle East Respiratory Syndrome Coronavirus Spike Protein

So-Young Lee iD, Hye-Min Woo, Hyunbum Jeon iD, Nayoung Kim, Da Sol Kim iD, Chan Ki Park, Hyun-Joo Kim iD, Kyung-Chang Kim iD, Joo-Yeon Lee iD, Kunwoong Park iD, Youngki Yoo iD, Kiju Choi iD und 1 weitere

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiaf202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von So-Young Lee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Emerging Virus and Vector Research, Center for Emerging Virus Research, Korea National Institute of Health, Korea Disease Control and Pre…. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, Middle East Respiratory Syndrome Coronavirus, Antibodies, Neutralizing, Antibodies, Viral. Die Arbeit nennt 40 Literaturangaben. Gefördert von: the National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in 2012 and has since spread worldwide. To date, no vaccines or therapeutics against MERS-CoV have been approved for clinical use. The spike protein of MERS-CoV facilitates attachment and fusion with target cell membranes. Therefore, inhibiting S protein attachment represents a key therapeutic strategy for treating early MERS-CoV infection. Herein, we present 7 human neutralizing antibodies (KNIH-58, -68, -72, -78, -88, -90, and -95) against MERS-CoV. KNIH-58 and -68 bound to the receptor-binding subdomain (RBD) of the spike protein, while the other 5 monoclonal antibodies did not. KNIH-88, which targets the non-RBD region, exhibited potent neutralizing activities in vitro and in a transgenic mouse model, with similar results for KNIH-58. Structural analysis of KNIH-88 bound to the spike protein revealed novel epitopes in the non-RBD region. These findings may facilitate therapeutic and prophylactic antibody development against MERS-CoV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusMiddle East Respiratory Syndrome CoronavirusAntibodies, NeutralizingAntibodies, ViralAntibodies, MonoclonalCoronavirus InfectionsAnimalsHumansMiceMice, TransgenicEpitopesFemaleProtein DomainsNeutralization Tests

Stichwörter der Autor:innen

Middle East respiratory syndrome coronavirusmonoclonal antibodiesneutralizing antibodyreceptor-binding domainspike protein

Substanzen

Spike Glycoprotein, CoronavirusAntibodies, NeutralizingAntibodies, ViralAntibodies, MonoclonalEpitopes

Autor:innen und Institutionen

  • Division of Emerging Virus and Vector Research, Center for Emerging Virus Research, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju-si, Republic of Korea.
  • Division of Structural Biology, Baobab AiBIO, Incheon, Republic of Korea.
  • Center for Emerging Virus Research, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju-si, Republic of Korea.

ORCID-Profile: So-Young Lee, Hyunbum Jeon, Da Sol Kim, Hyun-Joo Kim, Kyung-Chang Kim, Joo-Yeon Lee, Kunwoong Park, Youngki Yoo, Kiju Choi, Hansaem Lee

Förderung

  • the National Institute of Health

Zitieren

APA

Lee, S. Y., Woo, H. M., Jeon, H., Kim, N., Kim, D. S., Park, C. K., Kim, H. J., Kim, K. C., Lee, J. Y., Park, K., Yoo, Y., Choi, K., & Lee, H. (2025). A Novel Antibody Against the Non–Receptor-Binding Domain Region of Middle East Respiratory Syndrome Coronavirus Spike Protein. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf202

Vancouver

Lee SY, Woo HM, Jeon H, Kim N, Kim DS, Park CK, et al. A Novel Antibody Against the Non–Receptor-Binding Domain Region of Middle East Respiratory Syndrome Coronavirus Spike Protein. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf202

BibTeX
@article{Lee2025,
  author = {Lee, So-Young and Woo, Hye-Min and Jeon, Hyunbum and Kim, Nayoung and Kim, Da Sol and Park, Chan Ki and Kim, Hyun-Joo and Kim, Kyung-Chang and Lee, Joo-Yeon and Park, Kunwoong and Yoo, Youngki and Choi, Kiju and Lee, Hansaem},
  title = {A Novel Antibody Against the Non–Receptor-Binding Domain Region of Middle East Respiratory Syndrome Coronavirus Spike Protein},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiaf202}
}
Kostenlos starten →